Doximity Stock News

Doximity has cultivated a strong brand name among healthcare professionals.

It got too high, too fast.

Dr. Martens shares briefly fell below their IPO price from a year ago after private-equity giant Permira sold a swathe of shares at a discount.

TVTY vs. DOCS: Which Stock Is the Better Value Option?

This social media app has everything going right for it.

These two stocks could provide life-changing returns in 10 years.

This month, Doximity issued its Fifth Annual 2021 Physician Compensation Report. With the continued strain of the pandemic spanning 2021, the self-reported physician data reflected widespread burnout and early retirement, especially by female physicians…... By: Jackson Lewis P.C.

Doximity (NASDAQ:DOCS) and Powerbridge Technologies (NASDAQ:PBTS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability. Analyst Recommendations This is a breakdown of current ratings for Doximity and Powerbridge Technologies, as provided by []

Doximity Inc. (NYSE:DOCS) traded at $48.39 at close of the session on Monday, 12/20/21, made a downward move of -3.37% on its previous days price. Looking at the stock we see that its previous close was $50.08 with the days price range being $46.35 $50.19. In terms of its 52-week price range, DOCS has Take A Look At This Doximity Inc. (NYSE: DOCS) Analysis Before You Invest Read More »

Doximitys (NASDAQ:DOCS) lock-up period will expire on Tuesday, December 21st. Doximity had issued 23,300,000 shares in its IPO on June 24th. The total size of the offering was $605,800,000 based on an initial share price of $26.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the []

Doximity (NASDAQ:DOCS) had its price objective lowered by Morgan Stanley from $72.00 to $58.00 in a research note released on Friday, Benzinga reports. The firm currently has an equal weight rating on the stock. DOCS has been the topic of a number of other reports. SVB Leerink upped their price objective on Doximity from $65.00 []

Doximitys (NASDAQ:DOCS) lock-up period is set to end on Tuesday, December 21st. Doximity had issued 23,300,000 shares in its public offering on June 24th. The total size of the offering was $605,800,000 based on an initial share price of $26.00. After the expiration of Doximitys lock-up period, major shareholders and company insiders will be able []

Doximity (NASDAQ:DOCS) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a report issued on Friday, Zacks.com reports. The brokerage presently has a $55.00 price target on the stock. Zacks Investment Researchs target price would suggest a potential upside of 9.82% from the stocks current price. According to Zacks, []

Doximity, Inc. (NASDAQ:DOCS) Investment analysts at Jefferies Financial Group boosted their Q2 2023 earnings per share (EPS) estimates for Doximity in a note issued to investors on Wednesday, December 15th. Jefferies Financial Group analyst G. Santangelo now expects that the company will post earnings of $0.19 per share for the quarter, up from their []

Global IPOs have raised $453 billion in proceeds, representing a 67% increase year-over-year and a more than doubling from 2019 levels.